Medscape

Medscape

Medscape is an online platform designed for doctors and healthcare experts. It offers original medical journal articles that have been peer-reviewed, Continuing Medical Education (CME) resources, and a tailored version of the National Library of Medicine's MEDLINE database. Users can also access daily updates on medical news, extensive coverage of significant conferences, and detailed drug information, which includes the Medscape Drug Reference (MDR) and a tool for checking drug interactions. While all content on Medscape is free for both professionals and the public, users must register to access it.

National, Trade/B2B
Dutch, English, French, German, Portuguese, Spanish
Online/Digital

Outlet metrics

Domain Authority
89
Ranking

Global

#6059

United States

#2394

Health/Medicine

#13

Traffic sources
Monthly visitors

Articles

  • 1 day ago | medscape.com | Batya Swift Yasgur

    Cardiovascular disease (CVD) is the leading cause for premature mortality in patients with mental illness, particularly those with severe psychiatric disorders. The numbers bear out the link: The life expectancy of a person with severe mental illness is 15-20 years shorter than that of unaffected individuals, largely thanks to the effects of cardiac conditions.

  • 3 days ago | medscape.com | Randy Dotinga

    Roxana Daneshjou, MD, PhD, is one of the leading experts on artificial intelligence (AI) in American dermatology.

  • 3 days ago | medscape.com | Whitney McKnight

    Cannabis use in older adults is up, according to researchers who used a national survey database to study emergent patterns in older adult use of the substance. Their results were published online in JAMA Internal Medicine. After noting an upward trend in seniors using cannabis — from 1.0% in 2005 to 4.2% in 2018— a group of investigators led by Benjamin H.

  • 3 days ago | medscape.com | Fernando Fuentes

    In Latin America, efforts to implement preventive strategies, diagnostic tools, and personalized treatment for patients with rheumatic diseases often face significant barriers. However, there have been promising developments, many of which have been driven by the growing field of genomic medicine. One such initiative is the Ibero-American Research Consortium on the Genetics of Rheumatic Diseases (IARGE-RD).

  • 4 days ago | medscape.com | Kate Johnson

    The addition of postsurgical atezolizumab immunotherapy to standard-of-care chemotherapy in patients with stage III deficient DNA mismatch repair (dMMR) colon cancer significantly improved survival in the phase 3 ATOMIC trial. “These data established this combination as a new standard treatment for patients with stage III colon cancer and deficient mismatch repair,” said study author Frank A.